Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12608000576325Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in Nausea and Vomiting comparing Ondansetron IM, Midazolam IM and Metoclopramide IM control (3 arms). Primary endpoint: Reduction in nausea and vomiting. Planned start Nov 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12608000576325.